Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
Recursion Pharmaceuticals Q2 2024 Earnings Call - Five Programs with Clear Catalysts and 30% OpEx Cut
Recursion Pharmaceuticals is moving from AI promise to clinical proof, anchored by five wholly owned programs with defined inflection points over the next 12 to 18 months. The company delivered early ...
- Recursion has five wholly owned programs with clear clinical inflection points expected over the next 12 to 18 months, creating a consistent cadence of catalysts.
- REC-1245, an RBM39 degrader for solid tumors and lymphoma, showed a well-tolerated safety profile with no dose-limiting toxicities and confirmed target engagement in early Phase I data.
- REC-4539, an LSD1 inhibitor designed to mitigate on-target thrombocytopenia, has dosed its first patient in a Phase I trial for solid tumors including small cell lung cancer.
- +7 more takeaways
Imunon Q1 2026 Earnings Call - OVATION 3 Enrollment Gains Traction as Management Targets Non-Dilutive Financing
Imunon (IMNN) reported first-quarter 2026 results that underscore a strategic pivot toward capital preservation as it pushes its pivotal OVATION 3 trial for IMNN-101 into full gear. Management highlig...
- OVATION 3 Enrollment Pace: Patient enrollment for the pivotal Phase III trial is tracking ahead of internal monthly targets, with management projecting approximately 80 patients enrolled by the end of Q1 2027.
- Full Enrollment Timeline: The company has set a definitive target to fully enroll the 500-patient OVATION 3 trial by the first quarter of 2029.
- Phase II Data Strength: The final analysis of the completed OVATION 2 Phase II study showed a clinically meaningful 14.7-month median overall survival benefit for IMNN-101 combined with standard of care chemotherapy.
- +7 more takeaways
Broadwind {Q1} {2026} Earnings Call - Strategic Pivot to Power Generation and Defense Drives Record Backlogs and Margin Expansion
Broadwind is executing a decisive exit from its policy-dependent wind tower business, completing the divestiture of its Abilene facility by Q3 2026. This strategic pivot redirects capital and manufact...
- Broadwind is accelerating its exit from the wind tower market, with the sale of its Abilene facility closing post-Q1 2026 and all wind-related operations winding down by Q3 2026.
- Industrial Solutions reported record orders of $14.6 million in Q1, driving a new backlog high of $43.3 million, up more than $5 million from the previous peak.
- Gearing segment orders surged 66% year-over-year to $13.2 million, supported by a $30.5 million backlog, fueled by power generation and natural gas turbine demand.
- +7 more takeaways
Consolidated Water Company Q1 2026 Earnings Call - Manufacturing Revenue Collapses, Services Momentum Builds
Consolidated Water Company reported an 11% year-over-year revenue decline in Q1 2026, driven by a 76% collapse in manufacturing revenue and a 10.2% drop in retail volume due to unseasonably wet weathe...
- Total revenue fell 11% to $30 million year-over-year, dragged down by a $4.4 million plunge in manufacturing and an $834,000 decline in retail.
- Manufacturing revenue cratered 76% to $1.4 million due to unfavorable timing of purchase orders and a lack of large new contracts compared to the record-breaking 2025.
- Retail water sales in Grand Cayman dropped 10.2% in volume, directly correlated with significantly higher rainfall in Q1 2026 compared to the drought-like conditions of Q1 2025.
- +7 more takeaways
Stellus Capital Investment Corporation Q1 2026 Earnings Call - Dividend Sustainability Under Pressure as Non-Accruals Rise
Stellus Capital Investment Corporation reported a mixed first quarter, with core net investment income of $0.27 per share offset by a $0.28 per share decline in net asset value driven by dividend spil...
- Core net investment income came in at $0.27 per share, while GAAP NII was $0.26 per share. Total realized income reached $0.29 per share after a $750,000 gain on one equity position.
- Net asset value fell $0.28 per share, split between $0.08 from dividend spillover payments exceeding earnings and $0.20 in realized and unrealized losses tied to two debt investments.
- The portfolio closed at $990 million fair value across 116 companies, down from $1.01 billion in Q4 2025, with 99% of loans secured and 92% floating rate.
- +7 more takeaways
Intercorp Financial Services Q1 2026 Earnings Call - Record Net Income and Strategic InFinance Acquisition Drive Growth
Intercorp Financial Services delivered a record-breaking first quarter in 2026, with net income surging 35% year-over-year to PEN 602 million and return on equity climbing to 19.4%. The results were a...
- Record quarterly net income reached PEN 602 million, a 35% year-over-year increase, with return on equity hitting 19.4%.
- Higher-yielding loans grew 9% year-over-year, driven by strong performance in mortgages, mid-sized companies, and small business segments.
- Risk-adjusted net interest margin expanded 90 basis points year-over-year to 4.2%, supported by a record-low cost of risk of 1.4%.
- +7 more takeaways
Fortitude Gold Q1 2026 Earnings Call - Crushing Capacity Triples as East Camp Drill Results Ignite 'Home Run' Hopes
Fortitude Gold is in the thick of a multi-year rebuild. The company is operating three active sites while installing a massive new crushing system to triple throughput and chasing grid power that has ...
- Fortitude Gold officially commenced production at two new sites, County Line and Isabella Pearl Scarlett South, marking a major operational shift from single-mine dependency.
- The company installed and commissioned a larger crushing facility at the Isabella Pearl processing plant, originally sourced from the Golden Mile project, to handle increased throughput.
- The new crushing system is expected to more than triple processing capacity, moving from approximately 250 tons per hour to over 800 tons per hour.
- +12 more takeaways
VSE Corporation Q1 2026 Earnings Call - Record Q1 Results and PAG Acquisition Drive Margin Expansion
VSE Corporation delivered a record start to 2026, reporting Q1 revenue of $325 million, up 27% year-over-year, driven by balanced growth across distribution and MRO segments. The acquisition of Precis...
- VSE Corporation reported record Q1 2026 revenue of $325 million, a 27% year-over-year increase, with both distribution (+26%) and MRO (+28%) segments delivering strong growth.
- Organic revenue grew approximately 15% year-over-year, reflecting robust underlying demand across the business, with engine aftermarket activity now representing over 50% of total revenue.
- Adjusted EBITDA increased 37% to $55 million, with the adjusted EBITDA margin expanding 130 basis points to 17.1%, driven by higher-margin product mix, OEM licensed manufacturing, and early synergy realization.
- +7 more takeaways
Dr. Reddy's Laboratories Q4 FY2026 Earnings Call - Semaglutide Launches and Base Business Resilience Amid Lenalidomide Headwinds
Dr. Reddy’s Laboratories delivered a resilient FY2026, reporting record annual revenues of $3.63 billion despite a significant $50 million shelf stock adjustment on lenalidomide and several one-off im...
- Record FY2026 revenues of $3.63 billion, driven by underlying base business resilience despite product-specific headwinds.
- $50 million (INR 453 crores) self-stock adjustment on lenalidomide significantly impacted Q4 revenue and U.S. segment performance.
- Underlying base business delivered double-digit growth in Q4 and FY2026, with emerging markets and India leading the expansion.
- +7 more takeaways
Janus International Group Q1 2026 Earnings Call - Nokē Smart Security Gains Traction Amid North America Softness
Janus International Group delivered Q1 2026 revenue of $222.7 million, up 5.8% year-over-year, and adjusted EBITDA of $33 million. The company reaffirmed its full-year 2026 guidance of $940 million to...
- Q1 2026 revenue reached $222.7 million, up 5.8% year-over-year, while adjusted EBITDA came in at $33 million, down 14.1% year-over-year due to unfavorable geographic and product mix.
- Full-year 2026 guidance remains unchanged at $940 million to $980 million in revenue and $165 million to $185 million in adjusted EBITDA, with a midpoint margin of 18.2%.
- The Nokē smart security platform now has 477,000 installed units, a 24.2% year-over-year increase, with the upcoming Nokē Infinitē dual-technology lock designed to reduce battery maintenance costs.
- +7 more takeaways